Subhas C. Kundu is a Research Coordinator at 3Bs Research Group, University of Minho, Portugal. He completed his M.Sc and Ph.D. studies at Banaras Hindu University, Varanasi, India. He was the Founder Head and a Full Professor at the Department of Biotechnology, Indian Institute of Technology (IIT) Kharagpur (1994–2015) and a Distinguished Invited Professor at Dankook University (2016). In his early teaching career, he was an Assistant to a Full Professor and Head of the Department of Life Sciences at Manipur University, Imphal, India (1975–1973). He taught genetics, cell and molecular biology, and recombinant DNA technology to undergraduates, post-graduates and pre-doctoral students. He joined as European Research Area Chair Professor at 3Bs Research Group, University of Minho, in 2016, and later as Research Coordinator. His citation is 24 945, and his H-index is 75 (Google Scholar 09-10-2023). His research areas include natural biomaterial matrices, 3D cell culture, 3D in vitro cancer models, drug screening, and bioactive molecule delivery.
Subhas C. Kundu is a Research Coordinator at 3Bs Research Group, University of Minho, Portugal. He completed his M.Sc and Ph.D. studies at Banaras Hindu University, Varanasi, India. He was the Founder Head and a Full Professor at the Department of Biotechnology, Indian Institute of Technology (IIT) Kharagpur (1994–2015) and a Distinguished Invited Professor at Dankook University (2016). In his early teaching career, he was an Assistant to a Full Professor and Head of the Department of Life Sciences at Manipur University, Imphal, India (1975–1973). He taught genetics, cell and molecular biology, and recombinant DNA technology to undergraduates, post-graduates and pre-doctoral students. He joined as European Research Area Chair Professor at 3Bs Research Group, University of Minho, in 2016, and later as Research Coordinator. His citation is 24 945, and his H-index is 75 (Google Scholar 09-10-2023). His research areas include natural biomaterial matrices, 3D cell culture, 3D in vitro cancer models, drug screening, and bioactive molecule delivery.